Loading
institutionsInstitution
University Hospital Southampton / Centre for Cancer Immunology
Southampton's university hospital and the UK's first purpose-built cancer immunology centre, known for antibody engineering and lymphoma trials.
Also called: UHSSouthampton Centre for Cancer ImmunologyCRUK Southampton Centre
Overview
University Hospital Southampton is the tertiary cancer centre for central southern England, and the University of Southampton opened the Centre for Cancer Immunology in 2018, describing it as the UK's first dedicated centre of its kind. Martin Glennie and Mark Cragg's antibody groups defined how Fc receptors and antibody isotype govern anti-CD20, anti-CD40 and other immunomodulatory antibodies, and Peter Johnson led the RATHL trial that established PET-adapted treatment for advanced Hodgkin lymphoma. The Southampton Clinical Trials Unit and CRUK Southampton Centre run national trials in lymphoma, lung and gastrointestinal cancers and in DNA and peptide vaccines. The hospital houses a large children's oncology service and a Wessex regional genomics laboratory.
Location
Southampton, GB
Type
hospital · University of Southampton
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#74 · 44 points (0 Newsweek + 0 NCI + 44 from 22 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to University Hospital Southampton NHS Foundation Trust, including child institutions. 434 works · 3,990 citations · 78% open access · 11% clinical trials · 3% reviews.
Oncology works per year
992022
952023
812024
982025
612026
Most works
- Marc G. Besselink35 works
- Mohammad Abu Hilal27 works
- Zaed Hamady26 works
- Bas Groot Koerkamp24 works
- Keith Roberts19 works
- Bergþór Björnsson19 works
- Misha Luyer19 works
- Ugo Boggi18 works
- Ricky H. Bhogal18 works
- Andrew Davies18 works
Most cited
- Centre for Cancer Immunology
- Antibody biology and Fc engineering
- Lymphoma trials (RATHL)
- Southampton Clinical Trials Unit
- Cancer vaccines
Ellen Copson
Professor of Medical Oncology, University of Southampton; Consultant Medical Oncologist (breast), University Hospital Southampton
Early and metastatic breast cancerFamilial and young-onset breast cancerOncogenetics
First author of POSH, the UK prospective cohort of young-onset breast cancer that showed germline BRCA carriers did no worse than non-carriers, and the ones with triple-negative disease did better in the first two years.
John N. Primrose
Professor of Surgery, University of Southampton
Hepatobiliary surgeryBiliary tract cancerAdjuvant therapy trials
British surgeon who led BILCAP, the trial that made six months of capecitabine the standard after surgery for bile duct and gallbladder cancer.
Peter Johnson
Professor of Medical Oncology
LymphomaCancer immunotherapyMedical oncology
Southampton lymphoma specialist who led the RATHL trial of PET-guided therapy in Hodgkin lymphoma and serves as NHS England's National Clinical Director for Cancer.
Similar pages
- InstitutionRoyal Free Hospital, Royal Free London NHS Foundation Trust
Shares AMMF, the Cholangiocarcinoma Charity, Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer.
- InstitutionKing's College Hospital, London
Shares AMMF, the Cholangiocarcinoma Charity, Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer.
- InstitutionGlasgow Royal Infirmary
Shares EUROPAC, Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer.
- InstitutionNewcastle Cancer Centre / Northern Centre for Cancer Care
Shares EUROPAC, AMMF, the Cholangiocarcinoma Charity, Precision-Panc, UK specialist HPB cancer centres.
- PathwayComplement in cancer
Shares Fc engineering / effector function, ADCC (antibody-dependent cellular cytotoxicity), CD20, Chronic lymphocytic leukaemia.
- InstitutionAberdeen Royal Infirmary
Shares Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
- InstitutionCastle Hill Hospital, Hull (Queen's Centre)
Shares Precision-Panc, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.
- InstitutionDerriford Hospital, University Hospitals Plymouth
Shares EUROPAC, UK specialist HPB cancer centres, Gallbladder cancer, Pancreatic ductal adenocarcinoma.